Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-labelled, Randomized, Controlled, Clinical Trial to Evaluate the Immunogenicity and Tolerability of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine

NCT07457060 is registered in ClinicalTrials.gov with Sinovac Biotech Co., Ltd as lead sponsor.

NCT NCT07457060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07457060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-labelled, Randomized, Controlled, Clinical Trial to Evaluate the Immunogenicity and Tolerability of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Poliovirus Vaccine
Lead sponsor
Sinovac Biotech Co., Ltd
Phase
Phase 4
Overall status
Recruiting
Start date
November 27, 2025
Completion date
October 19, 2026
Enrollment
480 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

poliomyelitis